SoLAT (Sorafenib Lenvatinib alternating treatment): a new treatment protocol with alternating Sorafenib and Lenvatinib for refractory thyroid Cancer

被引:0
作者
Soo Young Kim
Seok-Mo Kim
Ho-Jin Chang
Bup-Woo Kim
Yong Sang Lee
Cheong Soo Park
Ki Cheong Park
Hang-Seok Chang
机构
[1] Yonsei University College of Medicine,Thyroid Cancer Center, Gangnam Severance Hospital, Department of Surgery
[2] Yonsei University College of Medicine,Department of Surgery
[3] Yonsei University,Yonsei Institute of Refractory Thyroid Endocrine Cancer
来源
BMC Cancer | / 18卷
关键词
Papillary thyroid cancer; Lenvatinib; Sorafenib; EMT; FGF signaling; TKI;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 270 条
[1]  
Nikiforov YE(2008)Thyroid carcinoma: molecular pathways and therapeutic targets Mod Pathol 21 S37-S43
[2]  
Schlumberger MJ(1998)Papillary and follicular thyroid carcinoma N Engl J Med 338 297-306
[3]  
Soares P(2011)Genetic alterations in poorly differentiated and undifferentiated thyroid carcinomas Curr Genomics 12 609-617
[4]  
Lima J(2012)Approach to the patient with anaplastic thyroid carcinoma J Clin Endocrinol Metab 97 2566-2572
[5]  
Preto A(2010)Thyroid cancer is the most common cancer associated with acromegaly Pituitary 13 242-248
[6]  
Castro P(2016)2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid Cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid Cancer Thyroid 26 1-133
[7]  
Vinagre J(2014)New therapeutic options for advanced forms of thyroid cancer Expert Opin Emerg Drugs 19 225-241
[8]  
Celestino R(2014)Stemness in human thyroid cancers and derived cell lines: the role of asymmetrically dividing cancer stem cells resistant to chemotherapy J Clin Endocrinol Metab 99 E400-E409
[9]  
Couto JP(2008)The epithelial-mesenchymal transition generates cells with properties of stem cells Cell 133 704-715
[10]  
Prazeres H(2016)Epithelial-mesenchymal transition confers resistance to selective FGFR inhibitors in SNU-16 gastric cancer cells Gastric Cancer 19 53-62